发布: 2012年12月20日第2卷第24期 DOI: 10.21769/BioProtoc.308 浏览次数: 21344
相关实验方案
来自骨髓增生性肿瘤患者的造血祖细胞的血小板生成素不依赖性巨核细胞分化
Chloe A. L. Thompson-Peach [...] Daniel Thomas
2023年01月20日 1464 阅读
Abstract
Osteosarcomas are the most common primary, non-hematologic malignant tumors in childhood and adolescence, comprising almost 60% of all bone sarcomas. Although these tumors are osteoblastic in nature, the characteristics of the specific tumor-initiating cells are unclear. Osteosarcomas contain highly proliferative undifferentiated malignant cells with a disrupted bone differentiation program. Cancer stem cells (CSCs) that have tumor-initiating properties and capacity of symmetric and asymmetric division have now been described in many solid tumors. For osteosarcomas, the CSC hypothesis has received support from recently reported findings that both human and murine osteosarcomas contain a sub-population of multipotent cells that that express various mesenchymal stem cell surface markers and are capable of undergoing differentiation in multiple mesenchymal lineages such as osteoblasts and adipocytes. Differentiation into these different lineages can be easily assessed by growing cells in specific medium and assaying for differentiation markers.
Materials and Reagents
Equipment
Procedure
文章信息
版权信息
© 2012 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
Basu-Roy, U., Basilico, C. and Mansukhani, A. (2012). Osteogenic and Adipogenic Differentiation of Osteosarcoma Cells. Bio-protocol 2(24): e308. DOI: 10.21769/BioProtoc.308.
分类
癌症生物学 > 癌症干细胞 > 细胞生物学试验
细胞生物学 > 细胞分离和培养 > 细胞分化
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link